Curanex Pharmaceuticals (CURX) vs Medicus Pharma (MDCX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Curanex Pharmaceuticals is the larger company by market cap ($7.5 million vs $7.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CURX | MDCX |
|---|---|---|
| Share price | $4.76 | $0.1019 |
| Market cap | $7.46M | $7.31M |
| 1-day change | -0.94% | -36.39% |
| YTD return | — | -93.34% |
| 1-year return | — | -95.86% |
| EPS (TTM) | $-7.80 | $-2.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.94 | $2.78 |
| 52-week low | $3.58 | $0.0941 |
| Distance from 52-week high | -71.90% | -96.33% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +4316.09% |
| Average volume | 19.85K | 4.43M |
| Shares outstanding | 1.57M | 71.71M |
| Employees | 6 | 16 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - General |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Curanex Pharmaceuticals
CURX stock →Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
Healthcare · Biotechnology · 6 employees
About Medicus Pharma
MDCX stock →Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Healthcare · Drug Manufacturers - General · 16 employees
CURX vs MDCX FAQ
Which is bigger, Curanex Pharmaceuticals or Medicus Pharma?
Curanex Pharmaceuticals (CURX) is larger, with a market capitalization of $7.46M compared with $7.31M for Medicus Pharma (MDCX).
Are Curanex Pharmaceuticals and Medicus Pharma in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for Curanex Pharmaceuticals and Drug Manufacturers - General for Medicus Pharma.